Clinical Trial Update: A Study to Compare Three Different Formulations of Tenofovir 1% Gel When Administered Rectally [Phase 1]

View source ↗

Summary

Phase 1 study comparing three rectal formulations of Tenofovir 1% gel for HIV prevention; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Tenofovir 1% gel (rectal formulation) (tenofovir)

Snippet

Sponsor: Ian McGowan | Conditions: HIV Prevention | Phase 1 | Status: COMPLETED